drugset / Trial / NCT04224818
Dual Trigger in the Final Oocyte Maturation in Poor Ovarian Responders
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a randomized controlled clinical trial to investigate the effect of dual trigger (hCG and GnRH agonist) on the final oocyte maturation compared to the standard hCG trigger in patients with poor ovarian reserve seeking IVF/ICSI treatment.
Timeline
- Start
- 2018-07-11
- Primary completion
- 2019-08-20
- Completion
- 2019-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Triptorelin | Other / unclassified | 0.3 mg | Subcutaneous |
| Background | human chorionic gonadotropin | Protein / enzyme biologic | 10000 iu | Subcutaneous |